Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Lymphoma 4Hodgkin Disease 4Lymphoma, Large-Cell, Anaplastic 3Lymphoma, Large B-Cell, Diffuse 3Waldenstrom Macroglobulinemia 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell, Peripheral 2Lymphoma, T-Cell, Cutaneous 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Follicular 2Lymphoma, Extranodal NK-T-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Intraocular Lymphoma 2Burkitt Lymphoma 2Testicular Neoplasms 1Sezary Syndrome 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pediatric Brain Tumor 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Neoplasms, Plasma Cell 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, AIDS-Related 1Leukemia, Myeloid, Acute 1

Interventions

High-Intensity Interval Training 1Diet, Ketogenic 1Control Groups 1Carmustine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Pediatric Brain Tumor × Carmustine × Clear all
NCT03591861 2022-12-12

Therapeutic Targeting of Sex Differences in Pediatric Brain Tumor Glycolysis

Washington University School of Medicine

Phase NA Terminated
2 enrolled

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡